This means that zinc, low dose HCQ, and azithromycin and may prevent a large number of hospitalizations and probably deaths during the SARS-CoV-2 pandemic.
Tag: COVID
We found a higher survival rate in patients treated with hydroxychloroquine and with macrolides in our study.
HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 115 studies to date is estimated to be 1 in 20 million (p = 0.000000049).
This study of critically ill patients with laboratory-confirmed COVID-19 admitted to ICUs in Mexico demonstrated that age and CRP levels upon ICU admission were associated with in-hospital mortality
BOMBSHELL. HCQ KILLS AN INDUSTRY BETTER THAN IT KILLS A VIRUS!!! You can stop wondering why it gets attacked. Here the answer!!
The FDA must remove its black-box warning, approve the emergency use authorization for outpatient HCQ use, and let doctors get on with the work of saving lives.
It’s a drug. It’s approved in the US. Has been for decades, if a doctor wishes to prescribe it, working with a patient, they may prescribe it for any purpose that they wish to do so.
Dr. Zelenko is demanding justice be served and calling on his over 100,000 Twitter followers to sign the petition.
This petition must be signed so as those responsible for the murder of countless lives can be brought to justice.
Our results can assure that hydroxychloroquine used for COVID-19 patients is safe, highly tolerable, and with minimum side effects.
If the ABC were doing their job, they’d be investigating the greatest scandal of our time – but they are infected with TDS, so they are not interested in the facts or the truth.
“That study found that 11 out of 11 studies that looked at Hydroxychloroquine used early as a treatment were all successful, they all reduced the rate of hospitalizations and death.
The aim of this study is to describe the characteristics and impact of different therapies on clinical outcomes in a cohort of severe COVID-19 patients.
Hydroxychloroquine, however, was associated with a 53% reduction of being transferred to the ICU.
valuable early outpatient therapy could be for millions of vulnerable adults in this country and around the world. Hydroxychloroquine may also play a role in reducing the risk faced by adults who are unwilling or unable to receive a COVID-19 vaccine.
Dr Peter McCullough explains how important early outpatient treatment is and presents guidelines for such treatment.
HCQ lowers the chance of transfer to the ICU by 53 percent. This is shown by research among 1064 patients.
HCQ has greater efficacy if given earlier in the course of the disease. Several negative studies have been withdrawn due to methodological improprieties.
I know I do catch COVID-19, I know what to take. My doctor has provided hydroxychloroquine, which I’m taking every day.
Brian Tyson, a doctor in Southern California has successfully treated over 1,700 patients with the drug hydroxychloroquine.
If these proffesionals all insist the evidence is overwhelming that this protocol is amazingly effective in correct, early use treatment of COVID-infected patients.
Hydroxychloroquine had a modest effect on hospital length stay and days in ICU compared with Standard Care.
Our findings indicate that Hydroxychloroquine can be an effective agent in postexposure prophylaxis.
So why is it that mainstream media will not push this type of information? The easy answer is MONEY! Hydroxychloroquine stands in the way of trillions of dollars.
Source: C19Study A live and ongoing index of studies from around the world documenting the use of hydroxychloroquine in treatment at various stages of SARS-CoV-2 infection including pre-exposure prophylaxis and post-exposure prophylaxis is available at https://c19study.com/, that also states whether the outcome was positive or negative. Overwhelmingly, PrEP, PEP, and early treatment studies show high effectiveness of […]
In our study, we found hydroxychloroquine wasn’t associated with significant arrhythmia clearly relating to hydroxychloroquine so it seemed the drug was very, very safe
The health bureaucrats have violated the first principle of the Hippocratic Oath , which is to do no harm.
In the first phase of the pandemic, 81% of deaths were in elderly homes. 50% of those deaths due to COVID-19 in nursing homes were avoidable with HCQ.
HCQ, combined with zinc, is a very effective treatment for COVID-19, especially if administered very soon after infection.
Therefore, Hydroxychloroquine is considered as the first‐line of COVID-19 treatment.
These results are evidences to support the early use of HCQ in post exposure prophylaxis.
Hydroxychloroquine + azithromycin had a significant effect on COVID-19 infected patients length of stay in the hospital.
There seems to be a trend towards lower mortality among patients who received treatment with the combination of hydroxychloroquine and azithromycin than among those who did not
Asian countries overall have fared better in controlling Covid-19, with lower mortality which is due to demographics and use of HCQ.
Patients in the Recovery Trial immediately receive 800 milligrams of hydroxychloroquine sulfate, yet the advised dosage is less than 500 mg for an adult man of average height